InnovaRx Innova Health Strategies

Z79.818

Long term (current) use of other agents affecting estrogen receptors and estrogen levels

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 2 never code together
Z79code
Excludes2
  • drug abuse and dependence (F11-F19)F11-F19
  • drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)O99.32-

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 12
Inclusion terms
  • Long term (current) use of estrogen receptor downregulators
  • Long term (current) use of fulvestrant (Faslodex)
  • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
  • Long term (current) use of goserelin acetate (Zoladex)
  • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
  • Long term (current) use of megestrol acetate (Megace)
Z79code
Includes
  • long term (current) drug use for prophylactic purposes
Code also
  • any therapeutic drug level monitoring (Z51.81)Z51.81
Z77-Z99block
Code also
  • any follow-up examination (Z08-Z09)Z08-Z09
Z00-Z99chapter
Notes
  • Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:Z00-Z99A00-Y89
  • (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
  • (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
Index entries leading here 2
  • Long-term (current) (prophylactic) drug therapy (use of)
    • agents affecting estrogen receptors and estrogen levels NEC Z79.818
    • estrogen receptor downregulators Z79.818
    • fulvestrant (Faslodex) Z79.818
    • gonadotropin-releasing hormone (GnRH) agonist Z79.818
    • goserelin acetate (Zoladex) Z79.818
    • leuprolide acetate (leuprorelin) (Lupron) Z79.818
    • megestrol acetate (Megace) Z79.818
  • Therapy
    • drug, long-term (current) (prophylactic)
      • agents affecting estrogen receptors and estrogen levels NEC Z79.818
      • estrogen receptor downregulators Z79.818
      • leuprolide acetate (leuprorelin) (Lupron) Z79.818
      • goserelin acetate (Zoladex) Z79.818
      • gonadotropin-releasing hormone (GnRH) agonist Z79.818
      • fulvestrant (Faslodex) Z79.818
      • megestrol acetate (Megace) Z79.818
Alongside this code 2 same parent — Z79.81
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
Z79.81
Block
Z77-Z99
Siblings
2

Present FY2024–FY2027.